Andrea Taddio

Type I interferon-mediated autoinflammation due to DNase II deficiency

Mathieu P. Rodero, Alessandra Tesser, Eva Bartok et al. · Nature Communications · 2017 · 228 citations · Full text

Life Sciences, Hematology, Immunology +17

Prevention of flare recurrences in childhood‐refractory chronic uveitis: An open‐label comparative study of adalimumab versus infliximab

Gabriele Simonini, Andrea Taddio, Marco Cattalini et al. · Arthritis Care & Research · 2010 · 200 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey

Marco Cattalini, Sara Della Paolera, Fiammetta Zunica et al. · Pediatric Rheumatology · 2021 · 127 citations · Full text

Medicine, Infectious Diseases, Pediatrics +9

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis

Gabriele Simonini, Andrea Taddio, Marco Cattalini et al. · Pediatric Rheumatology · 2013 · 95 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics

Marco Cattalini, Andrea Taddio, Claudia Bracaglia et al. · ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics · 2021 · 93 citations · Full text

Medicine, Infectious Diseases, Pediatrics +10